Aimee Jackson

University of Birmingham

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (5)

Graham McIlroy

NIHR Academic Clinical Lecturer in Haematology

University of Birmingham

UNITED KINGDOM

View details

Dorothee P. Auer

Director of MHCN / Director of Precision Imaging / Head of Radiological Sciences/Professor of Neuroimaging

University of Nottingham School of Medicine

UNITED KINGDOM

View details

Stefanie Thust

Clinical Associate Professor Neuroradiology

University of Nottingham

UNITED KINGDOM

View details

Sylvie Freeman

University of Birmingham

UNITED KINGDOM

View details

Justin Loke

University of Birmingham

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Aimee Jackson

Research Interests

Explore related searches

Contact this professor

Articles (9)

Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS

Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial

Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high‐risk acute myeloid leukaemia ineligible for intensive chemotherapy

Phase Ib study of eltrombopag and azacitidine in patients with high‐risk myelodysplastic syndromes and related disorders (the <scp>ELASTIC</scp> study)

A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trial.

Azacitidine for the treatment of steroid-refractory chronic graft-versus-host disease: the results of the phase II AZTEC clinical trial.

Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH)

Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia

De‐Iron: a phase 2 trial of the activity and safety of Deferasirox administered at early iron loading in patients with transfusion‐dependent myelodysplastic syndromes

Collaborators (5)

Graham McIlroy

Dorothee P. Auer

Stefanie Thust

Sylvie Freeman

Justin Loke

Make your next move.